Dizal Jiangsu Drug Patent Portfolio
Dizal Jiangsu owns 1 orange book drug protected by 3 US patents Given below is the list of Dizal Jiangsu's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11007198 | Erbb/Btk Inhibitors | 28 Jan, 2039 | Active |
| US11504375 | Erbb/Btk Inhibitors | 28 Jan, 2039 | Active |
| US11896597 | Erbb/Btk Inhibitors | 28 Jan, 2039 | Active |
Latest Legal Activities on Dizal Jiangsu's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Dizal Jiangsu.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Initial letter Re: PTE Application to regulating agency | 02 Sep, 2025 | US11504375 |
| Initial letter Re: PTE Application to regulating agency | 02 Sep, 2025 | US11007198 |
| Patent Term Extension Application under 35 USC 156 Filed | 27 Aug, 2025 | US11007198 |
| Patent Term Extension Application under 35 USC 156 Filed | 27 Aug, 2025 | US11504375 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 06 Nov, 2024 | US11007198 |
| Mail Patent eGrant Notification | 13 Feb, 2024 | US11896597 |
| Patent eGrant Notification | 13 Feb, 2024 | US11896597 |
| Recordation of Patent eGrant | 13 Feb, 2024 | US11896597 |
| Patent Issue Date Used in PTA Calculation | 13 Feb, 2024 | US11896597 |
| Email Notification | 13 Feb, 2024 | US11896597 |
| Recordation of Patent Grant Mailed | 13 Feb, 2024 | US11896597 |
| Email Notification | 25 Jan, 2024 | US11896597 |
| Issue Notification Mailed | 24 Jan, 2024 | US11896597 |
| Application Is Considered Ready for Issue | 18 Jan, 2024 | US11896597 |
| Dispatch to FDC | 18 Jan, 2024 | US11896597 |
Dizal Jiangsu's Family Patents
Dizal Jiangsu Drug List
Given below is the complete list of Dizal Jiangsu's drugs and the patents protecting them.
1. Zegfrovy
Zegfrovy is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11007198 | Erbb/Btk Inhibitors |
28 Jan, 2039
(12 years from now)
| Active |
| US11504375 | Erbb/Btk Inhibitors |
28 Jan, 2039
(12 years from now)
| Active |
| US11896597 | Erbb/Btk Inhibitors |
28 Jan, 2039
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zegfrovy's drug page